BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, June 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 6, 2012
View Archived Issues
New phase I data disclosed on KX2-391 in chemotherapy-naive bone-metastatic CRPC
Read More
OMP-59R5 well tolerated in phase I study
Read More
CalciMedica describes new class of immunomodulators
Read More
Clinical studies assess daily and twice-daily dosing of golvatinib
Read More
CHMP schedules hearing for Vivus' Qnexa MAA
Read More
Novel candidate cancer therapies created at Aurigene Discovery Technologies
Read More
Research alliance reached for carfilzomib and oprozomib
Read More
Phase III elagolix study begins in endometriosis
Read More
MebioPharm set to launch phase II/III MBP-426 trial
Read More
Portola Pharmaceuticals presents new SYK inhibitors
Read More
Dr. Reddy's Laboratories enters worldwide biosimilars collaboration
Read More
PharmaGap provides update on lead program
Read More
Roche expands gantenerumab trial in prodromal Alzheimer's disease
Read More
Preclinical study validates new target for resistant tumors
Read More
Phase I study evaluates peptide vaccine including cancer/testis antigens
Read More
Bayer designs novel guanylate cyclase activators
Read More
FDA sends complete response letter for ridaforolimus NDA
Read More
BioDiem to license new vaccine technology from Australian university
Read More
Kythera receives milestone payment from Bayer in ATX-101 collaboration
Read More
Research at U.S. university yields new anticancer agents
Read More
ProFibrix commences pivotal FINISH-3 study
Read More
Starpharma provides enrollment update for pivotal VivaGel studies
Read More
AVEO and Astellas planning new phase II study in RCC
Read More
Novel protein kinase inhibitors divulged
Read More
SDF-1 inhibition may limit transplant vasculopathy
Read More
